Is that $50M facility considered as cap raising if they want to tap into it? I can't see them developing Citronen with the marginal cost base and no trigger from Zinc price.
Could they be using the facility if indeed it is that to acquire a fast track operation perhaps? Other than that I don't see a need to raise capital. If it is for working capital then they should cut their base salary or get paid in options because that would not be an efficient use of capital to sit and wait for the zinc price to improve.
Is that $50M facility considered as cap raising if they want to...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IBG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.231M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 29596533 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 2799186 | 4 |
View Market Depth
| Last trade - 13.32pm 22/08/2024 (20 minute delay) ? |
| IBG (ASX) Chart |
Day chart unavailable